Genetic SpA

What Genetic SpA does

Genetic SpA is an Italian integrated pharmaceutical company headquartered in Fisciano, Italy, founded in 2000 and operating as a private joint-stock company (Società per Azioni) with 101-250 employees. The company's stated scope covers the research, development, manufacturing, and licensing of pharmaceutical products, alongside medical devices, positioning it as a vertically integrated mid-cap European pharma operator rather than a pure R&D biotech or pure generics distributor. Its business model combines proprietary drug/device manufacturing with licensing activities, which typically produces revenue from product sales (domestic and export markets) plus royalty or out-licensing income from partner arrangements. No product-level detail, therapeutic area focus, customer base, geographic footprint, pricing model, or management team information is disclosed in available sources, materially limiting financial and commercial underwriting. The only verifiable external signal is that CVC Capital Partners held a financial stake and divested in November 2025, realizing a 3.2x gross multiple of invested capital and a 25% IRR, suggesting the prior ownership cycle extracted reasonable value but not blockbuster returns relative to top-quartile PE outcomes.

Name

Genetic SpA

Website

https://geneticspa.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

101–250 employees

Short description

Genetic SpA is an Italian integrated pharmaceutical company, founded in 2000 and headquartered in Fisciano, focused on the research, development, manufacturing, licensing, and medical devices serving European and adjacent pharma markets.

Ownership category

akta.pro rank

Headquarters

HQ city

Fisciano

HQ country

Italy

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales

Core offering

Genetic SpA is an integrated pharmaceutical company that conducts pharmaceutical research and development, manufactures pharmaceutical products, licenses drug assets, and produces medical devices. The company spans the full drug-development value chain, from early-stage R&D through commercial manufacturing, and supplements its branded pharmaceutical business with medical device production.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Expansion highlights1 record

Direct peers

• Molteni Farmaceutici: Italian pharmaceutical manufacturer with in-house R&D and production of finished dosage forms, directly comparable in scale and integrated manufacturing focus to Genetic SpA.
• DOC Generici: Italian generics-focused pharmaceutical company competing on manufacturing and distribution of finished pharmaceutical preparations, directly overlapping Genetic SpA's manufacturing and licensing activities.

Regional players

• Alfasigma: Italian integrated pharmaceutical company engaged in R&D, manufacturing, and licensing of prescription and OTC products, closely mirroring Genetic SpA's integrated pharma model in the same domestic market.
• Italfarmaco: Italian pharmaceutical group spanning drug R&D, manufacturing, and specialty products, comparable to Genetic SpA as a mid-sized integrated Italian pharma manufacturer.
• Zambon: Italian pharmaceutical multinational focused on respiratory and specialty therapeutics with integrated manufacturing, overlapping Genetic SpA's integrated pharma and manufacturing activities.
• Dompé Farmaceutici: Italian biopharmaceutical company combining R&D and manufacturing of primary-care and biotech products, comparable to Genetic SpA as an integrated Italian pharma firm.
• Rottapharm: Italian pharmaceutical company with R&D, manufacturing, and licensing operations across prescription and consumer health, comparable to Genetic SpA's integrated domestic pharma profile.

Broad incumbents

• Recordati: Large Italian specialty pharma group covering R&D, manufacturing, and licensing across multiple markets; a scaled incumbent overlapping Genetic SpA's integrated model but far broader in reach.
• Menarini: Italy's largest privately held pharmaceutical company with integrated R&D, manufacturing, and global licensing, a broad incumbent in the same national pharma space as Genetic SpA.
• Chiesi Farmaceutici: Italian research-driven pharmaceutical group with strong respiratory and specialty franchises and integrated manufacturing, a larger incumbent operating in Genetic SpA's home market and category.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/genetic-spa

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genetic SpA